Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ferritin Level in Anemic Patients Can Indicate Colon Cancer

By HospiMedica staff writers
Posted on 17 May 2007
The ferritin level of an anemic person's blood may help healthcare providers decide whether to order a colonoscopy to see if colon cancer is the problem. More...


One of the leading reasons to look for colon cancer is the presence of iron-deficiency anemia, since bleeding from such a cancer may cause loss of iron from the body. Ferritin is a measure of how much iron your body has stored for future use; low levels are considered diagnostic of iron deficiency. However, other conditions (such as inflammation) may increase ferritin and hamper recognition of iron deficiency.

A study by investigators at the Minneapolis Veteran's Administration (VA) Hospital (MN, USA) found that looking at the ferritin level in individuals with anemia may provide additional information on risk of colon cancer. For this retrospective study, they examined the data on 414 people (almost all older men) who had a colonoscopy because they had anemia, and 323 people who had no symptoms or anemia but had a colonoscopy as a routine screening for colon cancer. All subjects in the study had no abdominal symptoms and no documented intestinal bleeding. The mean age of those studied was 69 years old. All those with anemia also had measurement of ferritin shortly before the colonoscopy was performed. The authors studied four groups: those with no anemia, and those with anemia who had ferritin levels that were low (50 ng/ml or less), low normal (51-100 ng/ml), or not low (above 100 ng/ml).

As expected, those with iron deficiency (low ferritin) were significantly more likely to have a cancerous or pre-cancerous condition in the colon (called advanced colonic neoplasia). However, those with anemia and low normal ferritin were just as likely to have advanced colonic neoplasia. In contrast, those with anemia but without low or low normal ferritin were no more likely to have advanced colonic neoplasia than those who did not have anemia.

When age was factored in, indivdiuals with serum ferritin levels below 100 ng/ml were almost five times more likely to have colon cancer or high-risk types of polyps, observed the investigators. For men with unexplained anemia, they concluded that a ferritin level below100 ng/ml is a reason to promptly refer these patients for colonoscopy. The test helps determine if the anemia is related to colon cancer.


Related Links:
Minneapolis VA Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.